Operational and Financial Results for the Period Ended September 30, 2020

NEXT STORY
United States $21.35 Bn Medical Equipment Maintenance Market to 2030
PREV STORY
Spring Bank Pharmaceuticals Stockholders Approve Combination with F-star Therapeutics
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Basilea reports significantly increased cash-generating revenue, flat operating expenses and reduced net loss for half-year 2019

author_avatar
NASDAQ Market News

INSYS Therapeutics Founder Dr. John N. Kapoor Steps Down from Board of Directors

PHOENIX, Oct. 29, 2017 (GLOBE NEWSWIRE) -- INSYS Therapeutics, Inc. (NASDAQ:INSY) (“INSYS” or “the ...

author_avatar
NASDAQ Market News

Aravive Presents Positive Data from Initial 12 Patients in Phase 1b Portion of its Phase 1b/2 Ovarian Cancer Study of AVB-500 in Late Breaking Oral Presentation at European Society for Medical Oncology Congress in Barcelona

author_avatar
NASDAQ Market News